openPR Logo
Press release

Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry | Global Anti-Viral Drug Therapy Market Research Report: Ken Research

02-18-2021 05:49 PM CET | Health & Medicine

Press release from: Ken Research Pvt Ltd

Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug

Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin.

According to study, “Anti-Viral Drug Therapy Global Market Report 2020-30: Covid 19 Implications and Growth” the key companies operating in the global anti-viral drug therapy market are Johnson & Johnson, Gilead Sciences Inc, Merck & Co., Inc, GlaxoSmithKline plc., AbbVie Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Dr. Reddy’s Laboratories Ltd, Boehringer Ingelheim, Hanmi Pharmaceutical, Cipla Inc, Daewoong Pharmaceutical Co. Ltd, KYORIN Holdings, Inc., Fosun Pharma, Jiangsu Hengrui Medicine Co., Ltd., Shanghai Pharmaceuticals, Yangtze River Pharmaceutical Group, Xian-Janssen Pharmaceutical Ltd, Harbin Pharmaceutical Group, Guangzhou Pharmaceutical Company Limited, Xian-Janssen Pharmaceutical Ltd, Harbin Pharmaceutical Group, Shanghai Acebright Pharmaceuticals Group Co., Ltd., Sinopharm Group, Lupin Limited, CSPC Pharmaceutical, China Meheco, Sun Pharma, Zydus Cadila, Divis Laboratories, Intas Pharmaceuticals, Alkem Laboratories, Strides Pharma, Takeda Pharmaceutical Company, Glenmark Pharmaceuticals, Nichi-Iko Pharmaceutical Co., Ltd., Otsuka Pharmaceutical, Chugai Pharmaceutical Co., Daiichi Sankyo, Mitsubishi Tanabe Pharma, Astellas Pharma, Shionogi Co. Ltd., Sumitomo Dainippon Pharma, Teva UK Limited, Eisai, AstraZeneca, Vectura Group, Abbott Laboratories, Roche Holding AG, Novartis AG, Hikma Pharmaceuticals, Pfizer, Pharmasyntez, Sanofi, ChemRar Group, R-Pharm, Pharmstandard, ChemRar Group, Alium, BioCryst Pharmaceuticals Inc., Servier, Novo Nordisk, Emergent BioSolutions, Selva Therapeutics, EMS Pharma, Apotex, Eurofarma, Cristalia, União Quimica, Gulf Pharmaceutical Industries, Libbs, Medical Appliances Corporation (SPIMACO), Saudi Pharmaceutical Industries, BMS, Mylan Laboratories, Ascedis Health. Key companies are increasingly focusing on development & launching of combination drug therapy to treat HIV and other viral infections. Combination therapies involve the formulation of different drugs to treat the different diseases.

Based on drug class, anti-viral drug therapy market is segmented as Protease Inhibitors, DNA (Nucleotide) Polymerase Inhibitors, Neuraminidase Inhibitors, Reverse Transcriptase Inhibitors and others. In addition, based on application, market is segmented as herpes, HIV, influenza, hepatitis and others.

The anti-viral drug therapy market is driven by rise in number of COVID-19 cases, followed by growth in development of drug discovery procedures. However, increase in pricing pressures and patent expiration may impact the market. Moreover, growth in development of advanced technologies is a key opportunity for market.

Based on geography, the North-American region dominates the global anti-viral drug therapy market owing to increase in virus life-threatening diseases like bird flu and strong development pipeline in the region. The Asian-Pacific and European regions are estimated to witness higher growth rate due to rise in healthcare expenditure coupled with growth in research & development (R&D) investments over the forecast period. It is anticipated that future of the global market as a result of increase in incidence rates of viral infections particularly HIV during the forecast period. It is also anticipated that global anti-viral drug therapy market will be reached at US $62.6 billion at a CAGR of 4.6% by 2023.

For More Information, Click on the Link Below:-

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. Ken Research provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Serving over 70% of fortune 500 companies globally, some of top consulting companies and Market leaders seek Ken Research’s intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry | Global Anti-Viral Drug Therapy Market Research Report: Ken Research here

News-ID: 2245059 • Views: 1118

More Releases from Ken Research Pvt Ltd

Increase in cybercrime results in India Digital Forensic Market to rise, with an expected CAGR of ~16% by 2028
Increase in cybercrime results in India Digital Forensic Market to rise, with an …
With the rise in digital threats and cybercrimes, India Digital Forensic Market makes successive changes like integration of Artificial Intelligence, and marking its overall growth. STORY OUTLINE Using techniques like Data Recovery, Log Analysis and more, India Digital Forensic Market enhances its Computer Forensics. Upgrades towards Network and Mobile Forensics are improving in cyber threats prevention, marking its increase in efficiency and security. With the incorporation of Cloud Based services, advanced methods and easy
Global Health Insurance market is expected to grow at a CAGR of ~6% by 2028: Ken Research
Global Health Insurance market is expected to grow at a CAGR of ~6% by 2028: Ken …
Due to recent pandemic of Covid 19 health insurance market has grabbed growth ensuring economic help to comman man for better health care facilities with easy money handling and increasing awareness especially after COVID 19. STORY OUTLINE Launch of new policies, mergers, acquisitions and partnerships to propel growth in future Covid 19 has a huge impact on the health insurance market on Global level. Factors, which are responsible for the growth, are the higher
Exploring the Investment Landscape in the UK Agricultural Equipment Market
Exploring the Investment Landscape in the UK Agricultural Equipment Market
Anticipated to achieve a CAGR of approximately 3.5% (2022-2027), the UK's agricultural equipment market expanded between 2014 and 2018, yet faced a significant downturn in 2019-2020 due to COVID-19. STORY OUTLINE The investment landscape in the UK agricultural equipment market is diverse, offering a spectrum of opportunities from established manufacturers to startups driving disruptive change. Investors can benefit from the technological prowess of leading manufacturers like John Deere, CNH Industrial, and AGCO Corporation
Unveiling the Thriving Landscape of UAE's IT Service Market
Unveiling the Thriving Landscape of UAE's IT Service Market
The IT services sector encompasses a diverse range of offerings, including but not limited to Cloud services, Cloud Applications, Datacenters, Artificial Intelligence (AI), Consulting Services, Connectivity Solutions, Security services, and other related services. STORY OUTLINE Digital Transformation Drive: UAE's IT market thrives on visionary government initiatives like "Smart Dubai" and "UAE Vision 2021," spurring sectoral evolution. Cloud's Ascendancy: Rapid cloud adoption, coupled with AI, IoT, and blockchain, reshapes industries for scalability and innovation. Security

All 5 Releases

More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications